Hepatitis C virus-induced liver disease is becoming a main indication
for liver transplantation. Recurrence of hepatitis after transplantati
on has been reported, but its long-term consequences are unknown. Seve
nty-nine patients positive for hepatitis C virus (group 1) and 106 sub
jects negative for hepatitis C virus antibody (group 2) with a mean fo
llow-up of 4 yr were retrospectively studied by means of serology, nes
ted polymerase chain reaction and branched-DNA technology before and a
fter liver transplantation. The actuarial rates of hepatitis C virus-r
elated acute hepatitis were 72% and 20% at 4 yr in groups 1 and 2, res
pectively. Progression to chronic active hepatitis occurred in 61% and
36% of the subjects within 3 yr of the onset of recurrent and acquire
d hepatitis, respectively. No case of acute graft failure and two case
s of cirrhosis were related to recurrent or acquired hepatitis C virus
liver disease. Hepatitis C virus RNA levels were significantly increa
sed in cases of hepatitis after transplantation. In contrast, the pret
ransplant hepatitis C virus RNA level was not predictive of recurrence
. Our results establish the general persistence of hepatitis C virus i
nfection after liver transplantation, the frequency and the severe cou
rse of recurrent liver disease. However, liver transplantation in hepa
titis C virus antibody-positive patients still has a good medium-term
prognosis.